Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 12, 2018
Validation and clinical application of an LC-MS/MS method for the quantification of everolimus using volumetric absorptive microsamplingR B Verheijen, B Thijssen, F Atrafi, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2014
Impact of pazopanib on docetaxel exposure: results of a phase I combination study with two different docetaxel schedulesP Hamberg, R H J Mathijssen, P de Bruijn, et al.
The Pharmacogenomics Journal|January 25, 2017
Genetic polymorphisms as predictive biomarker of survival in patients with gastrointestinal stromal tumors treated with sunitinibJ S L Kloth, M C Verboom, J J Swen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2013
Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancerR J van Soest, M E van Royen, E S de Morrée, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 27, 2024
Clinical implications of nintedanib pharmacokinetics in patients with pulmonary fibrosisB C Agema, M Berrich, L Seuren, et al.
British Journal of Cancer|August 12, 2010
The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancerL A Lammers, R H J Mathijssen, T van Gelder, et al.
Clinical Pharmacology and Therapeutics|September 20, 2012
OATP1B1 polymorphism as a determinant of erythromycin dispositionC S Lancaster, G H Bruun, C J Peer, et al.
ESMO Open|February 8, 2023
The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancerS M Buijs, E Oomen-de Hoop, C L Braal, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2015
The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancerR J van Soest, A J M Nieuweboer, E S de Morrée, et al.
Clinical Pharmacology and Therapeutics|May 24, 2012
Effects of CYP induction by rifampicin on tamoxifen exposureL Binkhorst, T van Gelder, W J Loos, et al.
Pageof 5